Validity of ART Adherence Self-Reports in Adults
Methods:A 12-month longitudinal cohort tracking of adherence measurement methods at three month intervals with comparison of levels of agreement (Kappa test) between two self-report methods and CD4 count change (CD4) was used. The pill-count method was used at 12 month of follow-up to validate both the self-reported and CD4 adherence. Survey data was used to explain possible causes of observed variability between methods.
Results: Moderate agreements between seven–day recall (7DR) and thirty–day recall (30DR) at three months (46.6%, p = 0.000); six months (46.2%, p = 0.001) and nine months (60.8%, p = 0.006). Excellent to moderate agreement between pill count (PC) and thirty – day recall at 12 months of follow up (agreement = 99.03%; p = 0.000); 7DR (64.57%; p = 0.452) and CD4 (52.87%; p = 0.186). Moderate to fair agreement between CD4 and 30DR (53.53%, p = 0.184) and 7DR (46.95%, p=0.905). Good agreement between CD4 and 30DR (64%, p = 0.000); and 7DR (37%, p = 0.030) at six months. Fair agreement between CD4 and 30DR (47%, p=) and 7DR (43%, p=) at nine months. Moderate agreement between CD4 and both 30DR (53%, p=0.17) and 7DR (54%, p=0.64) at twelve months.
Conclusions: CD4 count not a significant predictor of adherence in treatment experienced patients. Self reported methods useful in predicting adherence but need constant periodic validation with reliable methods like pill counts.